Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Applied Genetic Tech (AGTC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 82,651
  • Shares Outstanding, K 18,165
  • Annual Sales, $ 24,190 K
  • Annual Income, $ -21,300 K
  • 60-Month Beta 2.86
  • Price/Sales 3.48
  • Price/Cash Flow N/A
  • Price/Book 1.11

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.54
  • Number of Estimates 3
  • High Estimate -0.49
  • Low Estimate -0.57
  • Prior Year -0.45
  • Growth Rate Est. (year over year) -20.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.03 +12.90%
on 03/26/19
4.81 -5.41%
on 04/17/19
+0.30 (+7.06%)
since 03/18/19
3-Month
2.75 +65.45%
on 01/22/19
4.81 -5.41%
on 04/17/19
+1.65 (+56.63%)
since 01/18/19
52-Week
2.26 +101.33%
on 12/21/18
7.50 -39.33%
on 10/01/18
-0.50 (-9.90%)
since 04/18/18

Most Recent Stories

More News
Applied Genetic Technologies (AGTC) Upgraded to Strong Buy: What Does It Mean for the Stock?

Applied Genetic Technologies (AGTC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near...

AGTC : 4.55 (-1.94%)
American Gilsonite to Announce 4th Quarter 2018 Financial Results

American Gilsonite Company (the "Company" or "AGC"), the world's principal commercial miner and processor of uintaite, the unique mineral marketed under its trademark name "Gilsonite," today announced...

AGTC : 4.55 (-1.94%)
AGTC Announces Reaching Enrollment Milestones in Phase 1/2 Clinical Trials

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases,...

AGTC : 4.55 (-1.94%)
Will Applied Genetic Technologies Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor in Applied Genetic.

AGTC : 4.55 (-1.94%)
Applied Genetic Technologies: Fiscal 2Q Earnings Snapshot

ALACHUA, Fla. (AP) _ Applied Genetic Technologies Corp. (AGTC) on Thursday reported a loss of $4.2 million in its fiscal second quarter.

AGTC : 4.55 (-1.94%)
AGTC Announces Financial Results and Business Update for the Quarter Ended December 31, 2018

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases,...

AGTC : 4.55 (-1.94%)
Analysts Estimate Applied Genetic Technologies (AGTC) to Report a Decline in Earnings: What to Look Out for

Applied Genetic Technologies (AGTC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AGTC : 4.55 (-1.94%)
AGTC to Host Second Quarter Financial Results Conference Call and Webcast on February 7, 2019

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases,...

AGTC : 4.55 (-1.94%)
New Research: Key Drivers of Growth for Hewlett Packard Enterprise, Micron Technology, Cirrus Logic, Applied Genetic Technologies, KemPharm, and Communications -- Factors of Influence, Major Initiatives and Sustained Production

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Hewlett Packard Enterprise...

CRUS : 47.18 (+0.75%)
MU : 43.40 (+0.58%)
KMPH : 1.62 (-1.22%)
AGTC : 4.55 (-1.94%)
JCS : 2.81 (-2.82%)
HPE : 16.66 (+0.54%)
American Gilsonite to Announce 1st Quarter 2018 Financial Results

American Gilsonite Company (the "Company" or "AGC"), the world's principal commercial miner and processor of uintaite, the unique mineral marketed under its trademark name "Gilsonite," today announced...

AGTC : 4.55 (-1.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade AGTC with:

Business Summary

Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan ophthalmology diseases. Its lead product candidates in the preclinical stage include treatments for X-linked retinoschisis, Achromatopsia, and X-linked retinitis...

See More

Key Turning Points

2nd Resistance Point 4.91
1st Resistance Point 4.73
Last Price 4.55
1st Support Level 4.44
2nd Support Level 4.33

See More

52-Week High 7.50
Fibonacci 61.8% 5.50
Fibonacci 50% 4.88
Last Price 4.55
Fibonacci 38.2% 4.26
52-Week Low 2.26

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar